Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Brain Communications
|
December 22, 2025
Neurological, metabolic and inflammatory phenotypes in a mouse model of ECHS1 deficiency
Meghan M Eller, Aamir R Zuberi, Xiaorong Fu, et al.
Communications Medicine
|
January 27, 2025
Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
Maximiliano Presa, Rachel M Bailey, Somdatta Ray, et al.
Genes
|
September 23, 2022
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy
Kimberly Goodspeed, Judy S Liu, Kimberly L Nye, et al.
The Journal of Clinical Investigation
|
February 19, 2026
AAV-mediated gene therapy in a SLC13A5 citrate transporter disorder model rescues epileptic and metabolic phenotypes
Lauren E Bailey, Raegan M Adams, Morgan K Schackmuth, et al.
Gene Therapy
|
May 6, 2025
Nitrous oxide enhances MR-guided focused ultrasound delivery of gene therapy to the murine hippocampus
Deepshikha Bhardwaj, Ibrahim Youssef, Darren Imphean, et al.
Acta Neuropathologica
|
October 12, 2013
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
Rachel M Bailey, Jason P Covy, Heather L Melrose, et al.
The Journal of Clinical Investigation
|
April 20, 2021
AAV9-mediated FIG4 delivery prolongs life span in Charcot-Marie-Tooth disease type 4J mouse model
Maximiliano Presa, Rachel M Bailey, Crystal Davis, et al.
Parkinsonism & Related Disorders
|
April 3, 2007
Identification of potential protein interactors of Lrrk2
Justus C Dächsel, Julie P Taylor, Su San Mok, et al.
Muscle & Nerve
|
August 29, 2025
T2 Hyperintensities in Gracile Tracts of Cervical Spinal Cord in Giant Axonal Neuropathy (GAN)
Diane Armao, Thomas W Bouldin, Diana X Bharucha-Goebel, et al.
Genes
|
October 26, 2024
Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder
Raegan M Adams, Can Ozlu, Lauren E Bailey, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Brain Communications
|
December 22, 2025
Neurological, metabolic and inflammatory phenotypes in a mouse model of ECHS1 deficiency
Meghan M Eller, Aamir R Zuberi, Xiaorong Fu, et al.
Communications Medicine
|
January 27, 2025
Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
Maximiliano Presa, Rachel M Bailey, Somdatta Ray, et al.
Genes
|
September 23, 2022
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy
Kimberly Goodspeed, Judy S Liu, Kimberly L Nye, et al.
The Journal of Clinical Investigation
|
February 19, 2026
AAV-mediated gene therapy in a SLC13A5 citrate transporter disorder model rescues epileptic and metabolic phenotypes
Lauren E Bailey, Raegan M Adams, Morgan K Schackmuth, et al.
Gene Therapy
|
May 6, 2025
Nitrous oxide enhances MR-guided focused ultrasound delivery of gene therapy to the murine hippocampus
Deepshikha Bhardwaj, Ibrahim Youssef, Darren Imphean, et al.
Acta Neuropathologica
|
October 12, 2013
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
Rachel M Bailey, Jason P Covy, Heather L Melrose, et al.
The Journal of Clinical Investigation
|
April 20, 2021
AAV9-mediated FIG4 delivery prolongs life span in Charcot-Marie-Tooth disease type 4J mouse model
Maximiliano Presa, Rachel M Bailey, Crystal Davis, et al.
Parkinsonism & Related Disorders
|
April 3, 2007
Identification of potential protein interactors of Lrrk2
Justus C Dächsel, Julie P Taylor, Su San Mok, et al.
Muscle & Nerve
|
August 29, 2025
T2 Hyperintensities in Gracile Tracts of Cervical Spinal Cord in Giant Axonal Neuropathy (GAN)
Diane Armao, Thomas W Bouldin, Diana X Bharucha-Goebel, et al.
Genes
|
October 26, 2024
Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder
Raegan M Adams, Can Ozlu, Lauren E Bailey, et al.
Page
of 4